Health
Rare cancer drug to be subsidised – The Transcontinental
A drug to treat a rare stomach and bowel cancer will be subsidised after being listed on the Pharmaceutical Benefits Scheme….
A drug to treat a rare stomach and bowel cancer will be subsidised after being listed on the Pharmaceutical Benefits Scheme.
People suffering from advanced gastrointestinal stromal tumour will be able to buy the drug Qinlock for at most $41.30 per script…
Continue Reading
-
General21 hours agoForget a tariff-induced recession, Australians have been in recession for two years
-
Business21 hours agoWhere to invest $10,000 into ASX ETFs in April
-
Noosa News23 hours agoCameron Hunt assisting police with inquiries after his wife is found dead in suspicious Geham house fire outside of Toowoomba
-
Noosa News22 hours agoQueensland Opposition accuses government of ‘covering up’ Callide Power Station explosion